AstraZeneca PT010 Trial Meets Eight Out Of Nine Endpoints
LONDON (Alliance News) - AstraZeneca PLC said Sunday its trial of PT010 triple combination therapy in chronic obstructive pulmonary disease met eight of the nine primary lung function KRONOS Phase Read More